Acasti Pharma | ACST - Ebit

Stock Price
4.40
Daily Change
0.20 4.76%
Monthly
11.68%
Yearly
92.14%
Q1 Forecast
4.10

Acasti Pharma reported $-3.7M in EBIT for its fiscal quarter ending in December of 2024.





Ebit Change Date
Acasti Pharma USD -3.7M 1.13M Dec/2024
Addus HomeCare USD 42.28M 9.34M Dec/2025
Amarin USD -1.7M 8.47M Sep/2025
Cassava Sciences USD -11.86M 33.53M Sep/2025
Knight Therapeutics CAD 2.94M 2.4M Sep/2025
Option Care Health USD 91.5M 6.99M Dec/2025
Organigram Holdings CAD -28.05M 25.94M Sep/2025
Tilray USD -20.01M 9.34M Sep/2025